pI: 4.9876 |
Length (AA): 467 |
MW (Da): 51296 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | Procyclic, Bloodstream Form. | Siegel TN |
Siegel TN | Genome-wide analysis of mRNA abundance in two life-cycle stages of Trypanosoma brucei and identification of splicing and polyadenylation sites. |
Ortholog group members (OG5_128095)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G19180 | NEDD8-activating enzyme E1 catalytic subunit |
Babesia bovis | BBOV_I001030 | ThiF family domain containing protein |
Brugia malayi | Bm1_35445 | Ectopic membrane ruffles in embryo protein 1 |
Candida albicans | CaO19.11685 | Ubiquitin activating enzyme |
Candida albicans | CaO19.4209 | Ubiquitin activating enzyme |
Caenorhabditis elegans | CELE_F11H8.1 | Protein RFL-1 |
Cryptosporidium hominis | Chro.80201 | ubiquitin-activating enzyme |
Cryptosporidium parvum | cgd8_1730 | Uba3p like ubiquitin activating enzyme E1 |
Dictyostelium discoideum | DDB_G0283891 | NEDD8-activating enzyme E1 catalytic subunit |
Drosophila melanogaster | Dmel_CG13343 | Ubiquitin activating enzyme 3 |
Echinococcus granulosus | EgrG_000970100 | NEDD8 activating enzyme E1 catalytic subunit |
Entamoeba histolytica | EHI_098550 | ubiquitin-activating enzyme, putative |
Echinococcus multilocularis | EmuJ_000970100 | NEDD8 activating enzyme E1 catalytic subunit |
Homo sapiens | ENSG00000144744 | ubiquitin-like modifier activating enzyme 3 |
Leishmania braziliensis | LbrM.01.0690 | ubiquitin activating enzyme, putative |
Leishmania donovani | LdBPK_010730.1 | ubiquitin activating enzyme, putative |
Leishmania infantum | LinJ.01.0730 | ubiquitin activating enzyme, putative |
Leishmania major | LmjF.01.0710 | ubiquitin activating enzyme, putative |
Leishmania mexicana | LmxM.01.0710 | ubiquitin activating enzyme, putative |
Loa Loa (eye worm) | LOAG_01766 | ectopic membrane ruffles in embryo protein 1 |
Mus musculus | ENSMUSG00000030061 | ubiquitin-like modifier activating enzyme 3 |
Neospora caninum | NCLIV_040320 | ubiquitin-activating enzyme, putative |
Oryza sativa | 4325169 | Os01g0271500 |
Plasmodium berghei | PBANKA_0713800 | NEDD8-activating enzyme E1 catalytic subunit, putative |
Plasmodium falciparum | PF3D7_0817000 | NEDD8-activating enzyme E1 catalytic subunit, putative |
Plasmodium knowlesi | PKNH_0503400 | NEDD8-activating enzyme E1 catalytic subunit, putative |
Plasmodium vivax | PVX_089560 | ubiquitin-activating enzyme E1C, putative |
Saccharomyces cerevisiae | YPR066W | NEDD8-activating protein UBA3 |
Schistosoma japonicum | Sjp_0033200 | ko:K10686 ubiquitin-activating enzyme E1 C, putative |
Schistosoma japonicum | Sjp_0090040 | NEDD8-activating enzyme E1 catalytic subunit, putative |
Schistosoma japonicum | Sjp_0124080 | ko:K06917 tRNA 2-selenouridine synthase, putative |
Schistosoma japonicum | Sjp_0131750 | NEDD8-activating enzyme E1 catalytic subunit, putative |
Schistosoma mansoni | Smp_151760 | ubiquitin-activating enzyme E1C |
Schmidtea mediterranea | mk4.001703.08 | NEDD8-activating enzyme E1 catalytic subunit |
Trypanosoma brucei gambiense | Tbg972.9.2440 | ubiquitin-activating enzyme e1, putative |
Trypanosoma brucei | Tb927.9.4620 | NEDD8 activating enzyme subunit, putative |
Trypanosoma congolense | TcIL3000_9_1520 | ubiquitin-activating enzyme E1, putative |
Trypanosoma cruzi | TcCLB.510155.120 | ubiquitin activating enzyme, putative |
Trypanosoma cruzi | TcCLB.511585.130 | ubiquitin activating enzyme, putative |
Toxoplasma gondii | TGME49_264880 | NEDD8-activating enzyme E1 catalytic subunit |
Theileria parva | TP01_0601 | hypothetical protein, conserved |
Trichomonas vaginalis | TVAG_161040 | molybdopterin biosynthesis moeb protein, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb09.160.3210 this record | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb09.160.3210 this record | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb09.160.3210 this record | Trypanosoma brucei | significant gain of fitness in procyclic forms | alsford |
Tb09.160.3210 this record | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_F11H8.1 | Caenorhabditis elegans | embryonic lethal | wormbase |
TGME49_264880 | Toxoplasma gondii | Probably essential | sidik |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
Affected Entity | Phenotypic quality | Occurs in | Occurs at | Evidence | Observed in | Drugs/Inhibitors |
---|---|---|---|---|---|---|
cell proliferation (GO:0008283) | normal (PATO:0000461) | bloodstream stage trypomastigotes (PLO:0027) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in bloodstream forms (stage 6 days). | References: | 21363968 | |
cell proliferation (GO:0008283) | increased (PATO:0000470) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | increased cell proliferation (significant gain of fitness) in differentiation of procyclic to bloodstream forms . | References: | 21363968 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | ubiquitin-like modifier activating enzyme 3 | Compounds | References |
1 literature reference was collected for this gene.